Insomnia drug not responsible for Roseanne’s racist tweet; more pharmacies go under due to UK funding cuts; pharmacist murdered by husband
US: Pharma company Sanofi has hit back at claims by disgraced TV comedian Roseanne Barr that its insomnia drug Ambien was a cause of the racist tweet that has derailed her career.
The head of North American communications for Sanofi, Angela Bechan, told industry website Fierce Pharma that she “woke up on Wednesday to the news that actress Roseanne Barr had blamed a recent racist tweet on the use of the company’s insomnia drug, Ambien”. But Sanofi wasn’t having it.
Ms Bechan said Sanofi had responded by 9:57 a.m, with its own tweet from saying it “had responded to Barr’s charge that late-night “ambien tweeting” was responsible for her remarks”.
“People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world. While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication,” the company tweeted.
People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world. While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.
— Sanofi US (@SanofiUS) May 30, 2018
By the time Sanofi’s tweet went out on Wednesday morning, Barr had actually deleted the Ambien comment and another one that mentioned the drug, but her words were already out and the Twitterverse knew it. Overwhelmingly positive remarks and kudos poured in regarding Sanofi’s response.
In less than two hours, it had more than 60,000 likes and 25,000 retweets, Fierce Pharma reported.
“Ultimately at Sanofi we felt that using our medicines as a crutch for bad behavior is unacceptable. We have diversity and inclusion as a core belief here. We value diversity very much and we don’t feel there is any plausible defense for racism. We decided that we needed to stand by our beliefs and respond,” Bechan said.
London, UK: A total of 156 pharmacies have now closed in the wake of the funding cuts in England, new government data reveals.